About Us
Our Company
Our People
Pipeline
Pipeline
MFA011
Partnering
News
About Us
Our Company
Our People
Pipeline
Pipeline
MFA011
Partnering
News
Precise Antibody Engineering
About us
Our Company
Our People
Contact
Home
Our Science
Cytokine-Fusion Antibody
Novel T cell Targets
Precise Antibody Engineering
Partnering with Us
Pipeline
MFA011
MMB101
MMB102
MMB102
Pipeline
News
2020-05-27
MediMabBio establishes UK Subsidiary, MediMab Biotherapeutics
2019-02-19
MediMabBio Secures $3 Million Investment to Advance “New-Generation Cancer Treatment”
2017-07-26
MediMabBio Chosen for Up to $1 Million Funding from the TIPS Program
«
1
2
3